Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China
· Delayed Price · Currency is CNY 10.10
+0.28 (2.85%)
Apr 30, 2026, 3:04 PM CST
SHE:002873 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 9.11 | 52.32 | 80.87 | 111.52 | 100.61 | Upgrade
|
| Depreciation & Amortization | 37.68 | 37.38 | 23.34 | 25.45 | 22.81 | Upgrade
|
| Other Amortization | 6.8 | 1.61 | 1.47 | 1.28 | 2.69 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.78 | -18.9 | - | 0.02 | 0.1 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.16 | 0.71 | 0.07 | 0.12 | 0.37 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.02 | -0.02 | 0.72 | 0.4 | - | Upgrade
|
| Provision & Write-off of Bad Debts | -1.38 | 2.61 | -0.27 | 0.52 | 1.73 | Upgrade
|
| Other Operating Activities | 21.42 | 23.33 | 16.11 | 15.23 | 17.52 | Upgrade
|
| Change in Accounts Receivable | 49.95 | -38.03 | 7 | -20.18 | -8.45 | Upgrade
|
| Change in Inventory | -30.23 | 35.8 | -1.2 | -66.75 | -40.35 | Upgrade
|
| Change in Accounts Payable | -11.11 | -10 | -52.08 | 1.79 | 25.94 | Upgrade
|
| Operating Cash Flow | 83.73 | 88.13 | 77.78 | 75.82 | 124.3 | Upgrade
|
| Operating Cash Flow Growth | -4.99% | 13.30% | 2.59% | -39.00% | -29.28% | Upgrade
|
| Capital Expenditures | -51.59 | -61.45 | -101.7 | -129.2 | -105.69 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.14 | 15.08 | 5 | 0.03 | 0.08 | Upgrade
|
| Cash Acquisitions | -2.99 | - | - | - | - | Upgrade
|
| Investment in Securities | -40 | 0 | 0 | 50 | -112 | Upgrade
|
| Other Investing Activities | 0.01 | - | - | - | - | Upgrade
|
| Investing Cash Flow | -92.43 | -46.37 | -96.7 | -79.17 | -217.61 | Upgrade
|
| Long-Term Debt Issued | 532.75 | 680 | 506 | 347 | 273 | Upgrade
|
| Total Debt Issued | 532.75 | 680 | 506 | 347 | 273 | Upgrade
|
| Long-Term Debt Repaid | -421.63 | -577.29 | -404 | -278 | -418.63 | Upgrade
|
| Total Debt Repaid | -421.63 | -577.29 | -404 | -278 | -418.63 | Upgrade
|
| Net Debt Issued (Repaid) | 111.12 | 102.71 | 102 | 69 | -145.63 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 27.81 | Upgrade
|
| Repurchase of Common Stock | -5.44 | -129.48 | -2.99 | -3.1 | -15.02 | Upgrade
|
| Common Dividends Paid | -41.42 | -35.06 | -42.53 | -34.35 | -30.33 | Upgrade
|
| Other Financing Activities | - | - | - | - | -1.12 | Upgrade
|
| Financing Cash Flow | 64.25 | -61.83 | 56.48 | 31.54 | -164.3 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | 0 | - | - | Upgrade
|
| Net Cash Flow | 55.56 | -20.07 | 37.57 | 28.19 | -257.61 | Upgrade
|
| Free Cash Flow | 32.14 | 26.68 | -23.92 | -53.38 | 18.61 | Upgrade
|
| Free Cash Flow Growth | 20.48% | - | - | - | -82.71% | Upgrade
|
| Free Cash Flow Margin | 4.29% | 3.11% | -2.51% | -4.91% | 1.92% | Upgrade
|
| Free Cash Flow Per Share | 0.14 | 0.12 | -0.10 | -0.22 | 0.08 | Upgrade
|
| Cash Income Tax Paid | 86.33 | 79.86 | 97.63 | 117.84 | 112 | Upgrade
|
| Levered Free Cash Flow | 5.56 | -6.5 | -31.37 | -97.92 | -17.28 | Upgrade
|
| Unlevered Free Cash Flow | 16.66 | 4.48 | -23.99 | -91.24 | -6.9 | Upgrade
|
| Change in Working Capital | 9.15 | -10.9 | -44.54 | -78.71 | -21.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.